Start with the dispensing record
The name remembered by a patient may differ from the product a pharmacy dispensed. Ask for the drug name, strength, dosage form, fill date, quantity, days supplied and National Drug Code (NDC), when available. Keep labels and packaging photographs. A pharmacy may be able to help identify the manufacturer or labeler associated with each fill; do not assume every refill came from the same company.
Neurontin and generic gabapentin
The Drugs@FDA record for Neurontin capsules identifies gabapentin as the active ingredient and lists 100, 300 and 400 mg strengths. It also lists multiple generic products. This capsule record is not a complete inventory of every gabapentin formulation. Product identification requires your own records, not a guess based on a familiar brand name.
Keep pregabalin separate
Pregabalin, sold under the Lyrica brand as well as generically, is a different drug. A systematic review published June 22, 2026 discussed both medicines in the gabapentinoid category. A class-level association does not establish which medicine a person received or prove that either caused that person’s symptoms.
Build a useful timeline
Record first and last use, interruptions, dose changes and switches between medicines. Count pharmacy fills separately from pills taken or months treated. Preserve the prescribing reason, earliest cognitive symptoms, formal diagnosis and other medicines used around the same time. If a loved one is helping, identify who can authorize access to records.
You can request a review before every document is assembled. Missing records call for follow-up, not a conclusion that a claim qualifies or fails. JAG Legal Group evaluates the product, evidence and applicable law individually. See the full records checklist.
